Nausea and vomiting in patients admitted to the emergency department. Nausea and vomiting
Conditions
Interventions
Intervention 1: The first intervention group was injected with a conscious consent of 4 mg intravenous Ondansetron(Tehran chemistry company product) in single dose and nausea and vomiting are measu
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Nausea and vomiting in adult patients
Exclusion criteria
Exclusion criteria: Patients with symptoms such as headaches, lateralized symptoms, and unstable vital signs. Patients who have chest pain or ECG changes. Patients with symptoms of Rise ICP. Patients who have been taking sertonin (eg, fluoxetine, doxepin, isomerboxazide, amitriptyline, etc.) in the past few days. Patients who have used hepatic cytochrome P450 enzyme stimulating drugs or liver enzyme inhibitors in recent days. Patients who have consumed grapefruit in the past 24 hours Patient does not consent to attend or continue treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: 15minute ,30minute,45minute,60minute,75 minute,90minute after to take Granisetron or Ondansetron. Method of measurement: Using a visual analogue scaling method where the patient signs a nausea rate on a line measuring 10 cm in length from zero to ten.;Vomiting. Timepoint: 15,30,45,60,75,90minute after to take Granisetron or Ondansetron. Method of measurement: Count the number of vomiting. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlivefagh Nematollahi
Ahvaz University of Medical Sciences
Outcome results
None listed